Latest Breaking News On - ஶரிஂக் ப்லௌ நிறுவனம் - Page 3 : comparemela.com

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Reata Announces the Appointments of Christy J. Oliger and Shamim Ruff to Its Board of Directors Reata Pharmaceuticals, Inc.April 15, 2021 GMT PLANO, Texas, April 15, 2021 (GLOBE NEWSWIRE) Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced the appointments of Christy J. Oliger and Shamim Ruff to its Board of Directors, effective April 15, 2021. “We are excited to welcome Ms. Ruff and Ms. Oliger to Reata’s board,” said Warren Huff, Reata’s Chief Executive Officer and President. “They join at a critical point in Reata’s development having just submitted our first New Drug Application for bardoxolone methyl (“bardoxolone”) for the treatment of chronic kidney disease caused by Alport syndrome. Both Ms. Ruff and Ms. Oliger bring a wealth of experience that will be invaluable

United kingdomUnited statesAndres lorenteChristyj oligerManmeet soniUniversity of loughboroughSarepta therapeutics incMember of the royal society chemistryKaryopharm therapeutics incUniversity of leicesterRegulatory affairsStoke therapeutics incGenentech incExchange commissionUniversity of california at santa barbaraReata pharmaceuticals inc